{
  "subset": "contraindication",
  "disease": "Familial pulmonary fibrosis",
  "relation": "contraindication",
  "gold_drugs": [
    "bardoxolone methyl"
  ],
  "seeds_initial": [
    "Amiodarone",
    "Bleomycin",
    "Methotrexate",
    "Nitrofurantoin",
    "Cyclophosphamide",
    "Busulfan",
    "Chlorambucil",
    "Doxorubicin",
    "Carboplatin",
    "Gemcitabine",
    "Etoposide",
    "Interferon alfa",
    "Radiation therapy",
    "Sulfasalazine",
    "Valproic acid",
    "Ticlopidine",
    "Procarbazine",
    "Clofarabine",
    "Thalidomide",
    "Azathioprine",
    "Sodium salicylate",
    "Cisplatin",
    "Docetaxel",
    "Paclitaxel",
    "Tamoxifen",
    "Raloxifene",
    "Mifepristone",
    "Lopinavir",
    "Ritonavir",
    "Indinavir",
    "Nelfinavir",
    "Bromocriptine",
    "Ganciclovir",
    "Acyclovir",
    "Pentamadine",
    "Terbinafine",
    "Clofazimine",
    "Fingolimod",
    "Interferon beta",
    "Imatinib",
    "Dasatinib",
    "Nintedanib",
    "Afatinib",
    "Osimertinib",
    "Lemtrada",
    "Rituximab",
    "Benzodiazepines",
    "Methylprednisolone",
    "Prednisone",
    "Hydrocortisone",
    "Dexamethasone",
    "Narcotic analgesics",
    "Methadone",
    "Antitubercular drugs",
    "Sunitinib",
    "Tocilizumab",
    "Palbociclib"
  ],
  "seed_history": [
    [
      "Amiodarone",
      "Bleomycin",
      "Methotrexate",
      "Nitrofurantoin",
      "Cyclophosphamide",
      "Busulfan",
      "Chlorambucil",
      "Doxorubicin",
      "Carboplatin",
      "Gemcitabine",
      "Etoposide",
      "Interferon alfa",
      "Radiation therapy",
      "Sulfasalazine",
      "Valproic acid",
      "Ticlopidine",
      "Procarbazine",
      "Clofarabine",
      "Thalidomide",
      "Azathioprine",
      "Sodium salicylate",
      "Cisplatin",
      "Docetaxel",
      "Paclitaxel",
      "Tamoxifen",
      "Raloxifene",
      "Mifepristone",
      "Lopinavir",
      "Ritonavir",
      "Indinavir",
      "Nelfinavir",
      "Bromocriptine",
      "Ganciclovir",
      "Acyclovir",
      "Pentamadine",
      "Terbinafine",
      "Clofazimine",
      "Fingolimod",
      "Interferon beta",
      "Imatinib",
      "Dasatinib",
      "Nintedanib",
      "Afatinib",
      "Osimertinib",
      "Lemtrada",
      "Rituximab",
      "Benzodiazepines",
      "Methylprednisolone",
      "Prednisone",
      "Hydrocortisone",
      "Dexamethasone",
      "Narcotic analgesics",
      "Methadone",
      "Antitubercular drugs",
      "Sunitinib",
      "Tocilizumab",
      "Palbociclib"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_amiodarone",
          "name": "Amiodarone"
        },
        "score": 0.85,
        "graph_snapshot_ref": "GE_H1_round5",
        "key_assumptions": [
          "潜在肺部损伤链条的生成",
          "既往证据支持其对肺纤维化的危害"
        ],
        "caveats": [
          "可能存在增强肺部毒性的相互作用"
        ],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_bleomycin",
          "name": "Bleomycin"
        },
        "score": 0.85,
        "graph_snapshot_ref": "GE_H2_round5",
        "key_assumptions": [
          "Bleomycin已知与肺纤维化关系明确",
          "引导肺部损伤机制的充分证据"
        ],
        "caveats": [
          "已有临床依赖性导致的风险评估不足"
        ],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "score": 0.8,
        "graph_snapshot_ref": "GE_H5_round5",
        "key_assumptions": [
          "与副作用发生链条的关联性",
          "特定患者群体可能敏感"
        ],
        "caveats": [
          "与其他肺部有潜在负面影响的药物联合使用可能"
        ],
        "confidence": "high"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug → Familial pulmonary fibrosis",
          "reason": "高权重的Contraindication连接，支持候选药物的危害"
        }
      ],
      "remaining_gaps": [
        "尚需明确肺部毒性机制的具体路径图"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B",
            "C",
            "D"
          ],
          "impact_summary": "补齐了策略路径，临床证据强化"
        },
        {
          "round": 2,
          "seeds": [
            "E",
            "F"
          ],
          "impact_summary": "明确了对肺纤维化关系的多样性"
        }
      ],
      "lessons": [
        "优先关注对肺功能有已知影响的药物",
        "通过补充不同作用机制的候选确定风险"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "围绕肺毒性加强现有证据链的连贯性"
      },
      {
        "role": "Skeptic",
        "patch": "提供对比研究的数据支持，确认潜在风险"
      }
    ],
    "heuristics": [
      {
        "when": "已知对肺有害药物",
        "then": "优先过筛可能影响肺功能的剂量与疗程"
      },
      {
        "when": "使用肺毒性药物",
        "then": "在制定方案时考虑现有患者特征"
      }
    ]
  }
}